普和希PHCbi 日本三洋SANYO www.sanyo-biomedical.jp/china https://www.phchd.com/global/biomedical
三洋从1974年起开始制造医疗应用设备。到目前为止的发展经历中我们创造了很多辉煌,包括1991年制造出了世界上第一台-152℃超低温保存箱,在随后的1993年推出了使用我们自己的环保制冷剂的全系列冰箱与保存箱,并通过与行业领头羊ICI Chemicals & Polymers Ltd.的合作实现了跨越式的突破。我们把以人为主导型的款式设计作为我们的企业理念。我们设计与制造自己所拥有的压缩机,然后将之与我们的电子技术相结合创造出无与伦比的产品。性能、耐久性与快速的维护保养是我们的特点。三洋科研医疗设备现在已做好了挑战21世纪的准备,您可以确信它将继续支持我们在生理学、遗传学、滤过性微生物学、药理学及最尖端的生物学领域的处于领先地位。
Dalian SANYO Cold-Chain Co., Ltd.
No.6 Songlan Street, Economic & Technology Development Zone, Dalian, 116600 CHINA
Tel 0411-87544041
Fax 0411-87326912
大连三洋冷链有限公司
地址 大连经济技术开发区松岚街6号
电话 0411-87544041
传真 0411-87326912
SANYO Electric International Trading Co., Ltd.
24th Floor, Hang Seng Bank Tower, 1000 Lujiazui Ring Road, Pudong New Area, Shanghai, 200120 China
Free service call 800-988-1383
Tel +86-21-2022-2058
Fax +86-21-2022-0998
三洋电机国际贸易有限公司
地址 上海市浦东新区陆家嘴环路1000号恒生银行大厦24层
全国免費 800-988-1383
电话 021-2022-2058
传真 021-2022-0998
SANYO Electric (Hong Kong) Ltd - SSM Division
3/F, China Aerospace Center, 143 Hoi Bun Road, Kwun Tong, Kowloon, Hong Kong
Tel 852-2566-3456
Fax 852 2979 4092/852 2887 9545
Email thera @sanyocri.com
SCHMIDT BioMedTech (H.K.) Limited
20/F, Chinachem Exchange Square, 1 Hoi Wan Street, Quarry Bay, Hong Kong
Tel 852-2620-8329
Fax 852 2620 8397
E-mail alanho@schmidtbmtgp1.comSANYO began manufacturing equipment for medical applications in 1974. The highlights of our record so far include the world's first -152°C ultralow temperature freezer in 1991, followed in 1993 by the release of a full range of refrigerators and freezers using our CFC- free refrigerant, a breakthrough achieved in cooperation with industry-leader ICI Chemicals & Polymers Ltd. Our work is inspired by the concept Human-Oriented Design. We design and manufacture our own compressors, then match them with our electronics technologies to create unrivaled products. Performance, durability and speedy maintenance are our hallmarks. SANYO Research & Medical Equipment is ready for the challenges of the 21st century now, and you can be sure that we will continue to support advances in physiology, genetics, virology, pharmacology, and leading-edge biotechnology fields.